Enzyme-Activated Sugar-Coated Bifunctional Degraders

Targeted protein degradation with compounds like proteolysis targeting chimeras (PROTACs) directs disease-associated proteins to the E3 ligase ubiquitin-proteasome system for removal. However, commonly employed E3 ligases such as cereblon (CRBN) are broadly expressed. To metabolically gate PROTAC activity, we developed an enzymatic activation strategy by integrating an O-GlcNAc modification to the cyclimids, ligands derived from the natural motifs recognized by CRBN. These sugar-coated PROTACs (SCPs) were designed using structural analyses of representative cyclimid degraders complexed with CRBN and target protein BRD4. We found that glycosylation of the cyclimid reduced CRBN binding and complex formation with BRD4 until enzymatic removal of the O-GlcNAc moiety by O-GlcNAcase (OGA). The requirement for enzymatic activation is demonstrated by <i>in vitro</i> biochemical binding, cellular degradation, and cell viability assays in engineered and native cell lines. O-GlcNAc is thus an effective mechanism to gate targeted protein degradation modalities that motivates the development of similar strategies to enhance selectivity with other protein modifications.

Authors

Institutions

Publication Details

Journal
Journal of the American Chemical Society
Published
2025-09-12
DOI
https://doi.org/10.1021/jacs.5c09843
Citations
9
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
7.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enzyme-Activated Sugar-Coated Bifunctional Degraders

Zhi Yuan Lin, Dirk Kessler, Qian Zhu, Gerhard W. Fischer et al.
9 citations
Journal of the American Chemical Society
Protein Degradation and Inhibitors
7.25
article

Enzyme-Activated Sugar-Coated Bifunctional Degraders

Zhi Yuan Lin, Dirk Kessler, Qian Zhu, Gerhard W. Fischer, Alison C. Mody, N. Connor Payne, Dacheng Shen, Christina M. Woo, Daniel Peter, Ralph Mazitschek, Silvia Arce-Solano, S V Cheng
article en
9 citations

Abstract

Targeted protein degradation with compounds like proteolysis targeting chimeras (PROTACs) directs disease-associated proteins to the E3 ligase ubiquitin-proteasome system for removal. However, commonly employed E3 ligases such as cereblon (CRBN) are broadly expressed. To metabolically gate PROTAC activity, we developed an enzymatic activation strategy by integrating an O-GlcNAc modification to the cyclimids, ligands derived from the natural motifs recognized by CRBN. These sugar-coated PROTACs (SCPs) were designed using structural analyses of representative cyclimid degraders complexed with CRBN and target protein BRD4. We found that glycosylation of the cyclimid reduced CRBN binding and complex formation with BRD4 until enzymatic removal of the O-GlcNAc moiety by O-GlcNAcase (OGA). The requirement for enzymatic activation is demonstrated by <i>in vitro</i> biochemical binding, cellular degradation, and cell viability assays in engineered and native cell lines. O-GlcNAc is thus an effective mechanism to gate targeted protein degradation modalities that motivates the development of similar strategies to enhance selectivity with other protein modifications.

Journal of the American Chemical SocietyVol. 147(38)
Broad Institute (US), Boehringer Ingelheim (Germany) (DE), Harvard University (US), Harvard University Press (US), Massachusetts General Hospital (US), Boehringer Ingelheim (Austria) (AT), Center for Systems Biology (US)
Openalex Percentile: Top 2%
Protein Degradation and Inhibitors
7.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.